BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25329662)

  • 1. Applications of the Wei-Lachin multivariate one-sided test for multiple outcomes on possibly different scales.
    Lachin JM
    PLoS One; 2014; 9(10):e108784. PubMed ID: 25329662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of the Wei-Lachin multivariate one-directional test to multiple event-time outcomes.
    Lachin JM; Bebu I
    Clin Trials; 2015 Dec; 12(6):627-33. PubMed ID: 26336199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Closed testing using surrogate hypotheses with restricted alternatives.
    Lachin JM; Bebu I; Larsen MD; Younes N
    PLoS One; 2019; 14(7):e0219520. PubMed ID: 31299051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of composite time to first event versus joint marginal analyses of multiple outcomes.
    Bebu I; Lachin JM
    Stat Med; 2018 Nov; 37(27):3918-3930. PubMed ID: 29956365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some large-sample distribution-free estimators and tests for multivariate partially incomplete data from two populations.
    Lachin JM
    Stat Med; 1992 Jun; 11(9):1151-70. PubMed ID: 1509217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Group sequential large sample T2-like chi2 tests for multivariate observations.
    Lachin JM; Greenhouse SW; Bautista OM
    Stat Med; 2003 Nov; 22(21):3357-68. PubMed ID: 14566920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Group sequential monitoring of distribution-free analyses of repeated measures.
    Lachin JM
    Stat Med; 1997 Mar; 16(6):653-68. PubMed ID: 9131754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonparametric test of stochastic ordering for multiple longitudinal measures.
    Rosenberger WF; Lachin JM; Bain RP
    J Biopharm Stat; 1995 Nov; 5(3):235-43. PubMed ID: 8580926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Mean Vertigo Score (MVS) Outcome Scale and Its Use in Clinical Research for Quantifying Vestibular Disorders.
    Rahlfs VW; Zimmermann H
    Front Neurol; 2021; 12():601749. PubMed ID: 34025547
    [No Abstract]   [Full Text] [Related]  

  • 10. Weighted composite time to event endpoints with recurrent events: comparison of three analytical approaches.
    Ozga AK; Rauch G
    BMC Med Res Methodol; 2022 Feb; 22(1):38. PubMed ID: 35123397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of selected nonparametric tests for discrete longitudinal data under different patterns of missing data.
    Chirwa TF; Bogaerts J; Chirwa ED; Kazembe LN
    J Biopharm Stat; 2009; 19(1):190-203. PubMed ID: 19127475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sample size and power for a logrank test and Cox proportional hazards model with multiple groups and strata, or a quantitative covariate with multiple strata.
    Lachin JM
    Stat Med; 2013 Nov; 32(25):4413-25. PubMed ID: 23670965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninferiority trials with nonadherence to the assigned randomized treatment.
    Korn EL; Gray RJ; Freidlin B
    Clin Trials; 2019 Dec; 16(6):673-681. PubMed ID: 31409130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplicity adjustment for composite binary endpoints.
    Rauch G; Kieser M
    Methods Inf Med; 2012; 51(4):309-17. PubMed ID: 22525969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmenting the logrank test in the design of clinical trials in which non-proportional hazards of the treatment effect may be anticipated.
    Royston P; Parmar MK
    BMC Med Res Methodol; 2016 Feb; 16():16. PubMed ID: 26869168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procedures for comparing samples with multiple endpoints.
    O'Brien PC
    Biometrics; 1984 Dec; 40(4):1079-87. PubMed ID: 6534410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.
    Brookes ST; Whitley E; Peters TJ; Mulheran PA; Egger M; Davey Smith G
    Health Technol Assess; 2001; 5(33):1-56. PubMed ID: 11701102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rank-based sample size method for multiple outcomes in clinical trials.
    Huang P; Woolson RF; O'Brien PC
    Stat Med; 2008 Jul; 27(16):3084-104. PubMed ID: 18189338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.